Your cart is currently empty!
Categories
- BPC-157
- CJC-1295 (with DAC)
- CJC-1295 No Dac
- Epithalon
- Follistatin
- General Peptide
- GHK-cu (Copper Peptide)
- GnRH (Gonadotropin-Releasing Hormone)
- HCG (Human Chorionic Gonadotropin)
- Ipamorelin
- Kisspeptin
- Melanotan II (MT2)
- MK-677 (Ibutamoren)
- MOTS-c
- NAD+
- Oxytocin
- Peptide Storage
- Peptides
- PT-141 (Bremelanotide)
- Research Dosages
- Research Supplies
- Retatrutide
- Selank
- Semaglutide
- TB500 (Thymosin Beta-4)
- Tirzepatide
Social Links
Retatrutide Research Dosages
Below are potential future clinical trial dosages that might be explored for weight loss research based on studies cited by other research. *Administered subcutaneously 1x weekly Schedule Weekly Dose in Milligrams (mg) Weekly Dose Converted to Micrograms (mcg) Week 1 – 4 2 mg 2000 mcg Week 5 – 8 4 mg 4000 mcg Week…
Semaglutide Research Dosages
Below are suggested future clinical trial dosages that might be explored for weight loss research based-on studies performed for similar FDA approved GLP-1/GIP products that have already undergone several phases of clinical trials and testing. *Administered subcutaneously 1x weekly Schedule Weekly Dose in Milligrams (mg) Weekly Dose Converted to Micrograms (mcg) Week 1 –…
Tirzepatide Research Dosages
Below are suggested future clinical trial dosages that might be explored for weight loss research based-on studies performed for similar FDA approved GLP-1/GIP products that have already undergone several phases of clinical trials and testing. *Administered subcutaneously 1x weekly Schedule Weekly Dose in Milligrams (mg) Weekly Dose Converted to Micrograms (mcg) Week 1 –…